665
Participants
Start Date
June 30, 2012
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Eprosartan
Eprosartan 450 mg
Eprosartan Mesylate
Eprosartan mesylate 600 mg
Placebo Eprosartan mesylate
Placebo Eprosartan mesylate
Placebo Eprosartan
Placebo Eprosartan
Site Reference ID/Investigator# 74062, Berlin
Site Reference ID/Investigator# 93494, Hamburg
Site Reference ID/Investigator# 74064, Magdeburg
Site Reference ID/Investigator# 74066, Bochum
Site Reference ID/Investigator# 93495, Essen
Site Reference ID/Investigator# 93515, Frankfurt
Site Reference ID/Investigator# 74060, Frankfurt
Site Reference ID/Investigator# 93493, Karlsruhe
Site Reference ID/Investigator# 93514, Nuremberg
Site reference ID/Investigator # 82522, Saint Petersburg
Site reference ID/Investigator # 82517, Saint Petersburg
Site reference ID/Investigator # 82524, Saint Petersburg
Site reference ID/Investiragor # 82523, Saint Petersburg
Site reference ID/Investigator # 82519, Saint Petersburg
Site reference ID/Investigator # 82518, Saint Petersburg
Site reference ID/Investigator # 82527, Saint Petersburg
Site refernce ID/Investigator # 82521, Krasnodar
Site reference ID/Investigator # 82520, Kazan'
Site reference ID/Investigator # 82495, Novosibirsk
Site reference ID/Investigator # 82494, Novosibirsk
Site reference ID/Investigator # 82525, Novosibirsk
Site reference ID/Investigator # 82493, Kemerovo
Site reference ID/Investigator # 82516, Kemerovo
Site reference ID/Investigator # 82515, Barnaul
Site Reference ID/Investigator# 74065, Dresden
Site Reference ID/Investigator# 93513, Dresden
Site Reference ID/Investigator# 74063, Görlitz
Site Reference ID/Investigator# 74061, Leipzig
Site Reference ID/Investigator# 74057, Birmingham
Site Reference ID/Investigator# 74059, Cardiff
Site Reference ID/Investigator# 74056, Chorley
Site Reference ID/Investigator# 74054, Glasgow
Site reference ID/Investigator # 95456, Glasgow
Site Reference ID/Investigator# 74053, Liverpool
Site reference ID/Investigator # 95457, London
Site Reference ID/Investigator# 74055, Manchester
Site reference ID/Investigator # 95455, Northwood
Site Reference ID/Investigator# 74058, Reading
Lead Sponsor
Quintiles, Inc.
INDUSTRY
Synexus
OTHER
author! et al. BV
UNKNOWN
Abbott
INDUSTRY